David Southwell Insider Profile

4 Followers
David Southwell, Director at Rocket Pharmaceuticals, holds 114.78K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds ― shares in Spero Therapeutics (Ticker: SPRO), holds 14.50K shares in PTC Therapeutics (Ticker: PTCT).
tipranks
David Southwell

David Southwell
Rocket Pharmaceuticals (RCKT)
Director

Ranked #80,792 out of 99,218 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-32.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
57.58%
25.09%
17.34%
0.00%
A breakdown of David Southwell's holdings

Insider Roles

Rocket Pharmaceuticals
(RCKT)
Director
TScan Therapeutics
(TCRX)
CEO, Director
PTC Therapeutics
(PTCT)
Director
Spero Therapeutics
(SPRO)
Director
Roles that David Southwell holds in companies

Most Profitable Insider Trade

Stock:
TScan Therapeutics
(TCRX)
Rating:Informative Buy
Date:May 20, 2022 - May 20, 2023
Return:+4.90%
The most profitable trade made by David Southwell

David Southwell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Rocket Pharmaceuticals
May 20, 2024
Director
Uninformative Sell
$1.95M
Spero Therapeutics
Director
TScan Therapeutics
May 20, 2022
CEO, Director
Informative Buy
89.70K
$849.27K
PTC Therapeutics
May 10, 2024
Director
Uninformative Sell
$586.82K
FCRD
First Eagle Alternative Capital BDC
Dec 07, 2010
Informative Buy
157.28K
$174.79K
List of latest transactions for each holding click on a transaction to see David Southwell's performance on stock

David Southwell insider profile FAQ

What is the percentage of profitable transactions made by David Southwell?
The percentage of profitable transactions made by David Southwell is 33%.
    What is the average return per transaction made by David Southwell?
    The average return per transaction made by David Southwell is -32.80%.
      What stocks does David Southwell hold?
      David Southwell holds: RCKT, SPRO, TCRX, PTCT, FCRD stocks.
        What was David Southwell’s latest transaction?
        David Southwell latest transaction was an Uninformative Sell of ―.
          What was David Southwell's most profitable transaction?
          David Southwell’s most profitable transaction was an Informative Buy of TCRX stock on May 20, 2022. The return on the trade was 4.90%.
            What is David Southwell's role in Rocket Pharmaceuticals?
            David Southwell's role in Rocket Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.